Skip to main content
Home
  • Home
  • About us
  • Faculty
  • Brochure
  • Contact
Course finder
My Courses
Enter your CELforPharma username.
Enter the password that accompanies your username.
Show password
No account yet ? Create a profile
Forgot password ? Reset password
My account
Enter your CELforPharma username.
Enter the password that accompanies your username.
Show password
No account yet ? Create a profile
Forgot password ? Reset password
My Courses
Menu
  • Home
  • About us
  • Faculty
  • Brochure
  • Contact
Course finder My Courses
Home
Skip to main content
Your EU5 Market Access Acronyms / Abbreviations list
How to Measure the ROI of Your Digital Campaigns in Pharma
Prof. John Weinman explains the patient non-adherence problem and Pharma’s role
Test your knowledge of pharmaceutical licensing
Test Your Omnichannel Knowledge & Skills in Pharma
Why pharma product launches fail, according to Gary Johnson!
How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans
Tips for structuring a licensing deal between a biotech and a pharma company
Agile & Customer-Centric Brand Plan Quality Checklist
Do you know the difference between Health Economic Evaluations and Health Technology Assessments?
Preference scores from conjoint studies can be converted into useful market share estimates
Preparing for the EU Joint Clinical Assessment HTA Process
The 10 possible criteria in HTA – 10 tips
9,5 steps to a successful Advisory Board Meeting
What is a good Critical Success Factor (or: Strategic Imperative, Key Driver) for your brand in today’s VUCA pharma markets?
3 Main Challenges in Pharma Forecasting
The Power of Medical Insights for Success in Pharma
Test your knowledge of pharma sales forecasting
Omnichannel Budget Planning for the New Normal
Glossary of commonly misused pricing terms in pharma
Do you know the answer to this exercise on QALYs?
Do You Know the Key Drivers of Price Sensitivity for Pharmaceuticals?
4 Core MSL competencies – A training priority!
The 4 Payer Types to be Considered in Optimising Value Pricing in Pharma
Commonly Misused Pricing Terms in Pharma
6 Key Omnichannel Marketing Objectives and Strategies to Consider in Pharma
The Many Faces of a Full HTA
Do you have an effective market access planning process in place for new brands?
Not only is Market Access important, it also requires a new cross-functional approach
The Pharma Launch Readiness Self-assessment Tool
6 Domains of Specialist Medical Affairs Excellence (DMAX): Unlocking the Value of the Medical Affairs Role
Selecting the right MSL tactics based on Reach & Impact
Do You Know the 5 Categories of Payers and Their Respective Roles and Drivers?
10 Essential Steps for a Successful Pharma Launch
The power of the Net Promoter Score - An underutilised tool in the pharma industry
What Is an Epi-Based Forecast, As Opposed To a Sales-Based Forecast, and When Do You Need One?
What You Should Know About the QALY and About the Value of Health/QALY Gains with New Therapies
Challenges in Valuation: The In-Licensing Perspective – insightful 4-page article
Basics of Health Economics - Online Self-Study Programme: Preview
What is a QALY and how to calculate it? – By Prof. Dr. Lieven Annemans
Driving Lifecycle Management Excellence Across the Full Product Lifecycle
Integrative vs. Distributive Pharma Licensing Negotiation Strategies
The Value Dossier and Value Story
Designing a Strategic KOL Plan for Success
5 Key Components of Commercial Launch Excellence
The 5 most useful sales forecasting techniques for pharmaceuticals
The in- & out-licensing processes at a glance
What clinicians need (and want!) to know about the health economic profile of new pharmaceuticals
Are you correctly forecasting the uptake of your brand(s)?
The difference between Patient FLOW and Patient JOURNEY
Thinking With Data
Overview of the Different KOL Roles Across the Lifecycle of a Product
9,5 steps to a successful Advisory Board Meeting – Do you actually need one?
From Patient Insights to Key Growth Drivers for Pharmaceuticals
Artificial Intelligence: How effective is it for pharma pricing and forecasting? Knowing what works. Knowing what is just hype.
Mastering Pharma Licensing Negotiations: 6 Rules for a Value-Based Structured Approach
6 Principles of Pharmaceutical Sales Forecasting
Can you forecast the relationship between your level of promotion and your sales?
The Differences Between Multichannel and Omnichannel in Pharma
Checklist to Assess Pharma Brand Plan Insights
Test your understanding of SWOTs
7 Powerful negotiation tools used in Pharma Licensing Negotiations
5 Omnichannel Opportunities for Biopharma to Engage HCPs in the Medical Space
Do you know what a QALY is, and how to calculate it?
10 Critical Success Factors for Pharma Lifecycle Management
subscribe to our newsletter
Follow us on  Linkedin
© 2023 celforpharma.com - All rights reserved - Cookie settings
  • Privacy Policy
  • Transfer & Cancellation Policy
subscribe to our newsletter
Follow us on  Linkedin
  • Privacy Policy
  • Transfer & Cancellation Policy
© 2023 celforpharma.com - All rights reserved - Cookie settings
Create profile

Passwords do not match! Please try again.